Humacyte Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
The company stated in the following news article that they use animals for product testing.
“Low rates of graft failure are also consistent with the preclinical data from animal testing of HumaGraftTM demonstrated little intimal hyperplasia, which is a common cause of failure for current dialysis access products. Preclinical data also indicated that in animals, HumaGraftTM was remodeled to become living tissue in the recipient.” Read the following article
Humacyte, Inc. (Humacyte), formerly Alpha Healthcare Acquisition Corp., is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale. The Company uses its technology platform to engineer and manufacture human acellular vessels (HAVs).
Company Website: https://humacyte.com